Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AMRI acquires CMO OsoBio for $110mm

Executive Summary

Albany Molecular Research Inc. (AMRI; CRO) acquired private CMO Oso BioPharmaceuticals Manufacturing LLC (OsoBio; injectable drug manufacturing) for $110mm in cash.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Acquisition of Private Biotech
    • Payment Includes Cash
    • Full Acquisition

Related Companies